barium sulphate
Trade name: Varibar
Small moleculeapproved
Approved
Jan 11, 2016
D&C RED NO. 6 BARIUM LAKE belongs to the family of barium salt of carboxylic acid. It is used in cosmetic manufacturing practices. The combined total of D&C RED No. 6 and D&C RED No. 7 must not exceed 5mg per daily dose of a drug. — NCATS
Clinical trial activity
7 trials · 9 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
1
Earliest trial started Jul 1, 2004 (NCT00212433)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Diagnostic agent
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedJan 11, 2016
Chemistry & pharmacology
Loading structure…
SMILES
[Ba++].CC1=CC=C(\N=N\C2=C3C=CC=CC3=CC(C([O-])=O)=C2O)C(=C1)S([O-])(=O)=O- Mol. weight
- 521.69 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Oral
- Availability
- Prescription Only
Oral
Yes
Parenteral
No
Topical
No
Sources
- WikipediaBarium ↗
- NCATSK4XZD9W99K ↗
- ChEMBLCHEMBL2105897 ↗
- WikipediaBarium sulfate ↗
- NCATS25BB7EKE2E ↗
Also known as
- ba
- ba
- bacl2
- baricon
- baricon
- barium
- barium
- barium
- barium chloride
- barium chloride
- barium chloride
- barium chloride, (140)bacl2
- barium chloride, (153)bacl2
- barium chloride, dihydrate
- barium chloride, hexahydrate
- barium chloride, monohydrate
- barium chloride, octaammoniate
- barium dichloride
- barium sulfate
- barium sulfate
- barium sulfate
- barium sulfate
- barium sulfate
- barium sulfate
- barium sulfate
- barium sulfate
- barium sulfate
- barium sulphate
- barocat
- barocat
- barosperse
- barosperse
- barosperse ii
- barosperse ii
- barotrast
- barotrast
- bar-test
- bar-test
- epi-c
- epi-c
- epi-stat 57
- epi-stat 57
- epi-stat 61
- epi-stat 61
- esophotrast
- esophotrast
- oratrast
- oratrast
- taglitol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02662907 | N/A | Feb 1, 2016 | University of Texas at Houston |
| NCT02542046 | Phase 3 | Jan 1, 2015 | General Electric, University of California, San Francisco |
| NCT02661256 | N/A | Jun 1, 2014 | Winthrop University |
| NCT01882816 | Phase 2 | Jun 1, 2013 | Cornell University |
| NCT01379183 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2011 | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| NCT01183793 | N/A | Jul 1, 2010 | University of Nice Sophia Antipolis |
| NCT00212433 | Phase 4 | Jul 1, 2004 | University of London |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| General Electric | For profit | 1 | 0 | 1 | 2015 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2011 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 1 | 0 | 1 | 2011 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2004 |
| University of Nice Sophia Antipolis | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Winthrop University | Academic/Hospital | 1 | 1 | 1 | 2014 |
9 organizations
Page 1 / 1